Bridgeway Capital Management’s Rapid Micro Biosystems RPID Stock Holding History

Bridgeway Capital Management’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-138,000	Closed	-$181K	–	1439
2023 Q1	$181K	Hold	138,000	–	–	﹤0.01%	1122
2022 Q4	$156K	Buy	138,000 +69,500	+101%	+$168K	﹤0.01%	1140
2022 Q3	$221K	Buy	68,500 +40,000	+140%	+$155K	0.01%	1119
2022 Q2	$123K	Buy	+28,500	New	+$133K	﹤0.01%	1191

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bridgeway Capital Management's RPID Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Rapid Micro Biosystems (RPID) in Q2 2023, closing a stake of 138,000 shares — an estimated $181K sold.

Bridgeway Capital Management first reported a position in RPID in Q2 2022 and held it in 4 quarters. The position peaked at $221K in Q3 2022. 24 funds tracked by Wall St. Rank hold RPID as of Q2 2023.

Bridgeway Capital Management reported no remaining Rapid Micro Biosystems position as of Q2 2023 after selling out during the quarter.
Bridgeway Capital Management sold 138,000 Rapid Micro Biosystems shares in Q2 2023, an estimated $181K.
Bridgeway Capital Management first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 4 quarters.
Bridgeway Capital Management's Rapid Micro Biosystems position peaked at $221K in Q3 2022.
24 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.